rs750073618
Variant summary
The NM_006514.4(SCN10A):c.307C>T (p.Arg103Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000254 (AC=41) in the gnomAD database across 1,613,706 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000022. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R103Q: Likely_benign (ClinVar VariationId 532134, 2 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_006514.4 missense
Scores
Clinical Significance
Conservation
Publications
- episodic pain syndrome, familial, 2Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: PanelApp Australia, Ambry Genetics, Illumina, Labcorp Genetics (formerly Invitae)
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Brugada syndromeInheritance: Unknown, AD Classification: LIMITED, NO_KNOWN Submitted by: Genomics England PanelApp, ClinGen, G2P
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Likely_benign. The variant received -2 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PM2Absent/extremely low in population databases | Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.000022 — borderline rare for AD/XL gene (threshold 0.0001) — PM2 supporting. | ||
| PP3Computational evidence supports damaging effect | Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting). | ||
| BS2Observed in healthy adult | Pure AD gene with cumulative gnomAD AC ≥5 — observed in healthy adults (BS2); GnomAD homozygous count = 0.; Cumulative gnomAD AC = 41 (pure AD gene, not AR). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_006514.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN10A | MANE Select | c.307C>T | p.Arg103Trp | missense | Exon 3 of 28 | NP_006505.4 | Q9Y5Y9 | ||
| SCN10A | c.307C>T | p.Arg103Trp | missense | Exon 2 of 27 | NP_001280235.2 | Q9Y5Y9 | |||
| SCN10A | c.307C>T | p.Arg103Trp | missense | Exon 2 of 26 | NP_001280236.2 | Q9Y5Y9 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SCN10A | TSL:1 MANE Select | c.307C>T | p.Arg103Trp | missense | Exon 3 of 28 | ENSP00000390600.2 | Q9Y5Y9 | ||
| SCN10A | c.307C>T | p.Arg103Trp | missense | Exon 2 of 27 | ENSP00000495595.1 | A0A2R8Y6J6 | |||
| SCN10A | c.307C>T | p.Arg103Trp | missense | Exon 3 of 28 | ENSP00000499510.1 | A0A590UJM0 |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000197 | AC:3 | Hom:0 | AN:152106 | Cov:32 |
GnomAD2 exomes | AF: 0.00000398 | AC:1 | AN:250980 | ||
GnomAD4 exome | AF: 0.0000260 | AC:38 | Hom:0 | AN:1461600 | Cov:31 |
GnomAD4 genome | AF: 0.0000197 | AC:3 | Hom:0 | AN:152106 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000189 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:16840 | |
Local & regional cohorts 1 source | |||||
Turkish Variome | AF: 0.000647 | AC:1 | Hom:0 | AN:1546 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
ASC | 0.00 * | 0 | 9620 | 0.0000960 * | 1 | 10422 |
BipEx | 0.00 | 0 | 28406 | 0.0000694 | 2 | 28824 |
Epi25 | 0.00 | 0 | 41948 | 0.0000748 | 5 | 66860 |
SCHEMA | 0.00000885 | 1 | 113032 | 0.0000158 | 3 | 190456 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 25 | |
AlphaMissense | Pathogenic | 0.82 | |
BayesDel_addAF | Pathogenic | 0.35 | D |
BayesDel_noAF | Pathogenic | 0.26 | |
CADD | Uncertain | 24 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Uncertain | 0.77 | D |
Eigen | Uncertain | 0.61 | |
Eigen_PC | Uncertain | 0.49 | |
FATHMM_MKL | Uncertain | 0.91 | D |
FuncVEP CTI | Pathogenic | 0.98 | |
GPN-Star LLR | N/A | -8.5 | |
GPN-Star score | N/A | 8.5 | |
LIST_S2 | Pathogenic | 1.0 | D |
M_CAP | Pathogenic | 0.44 | D |
MetaRNN | Pathogenic | 0.92 | D |
MetaSVM | Pathogenic | 1.1 | D |
Mutation Taster | N/A | 42/58 | disease causing |
MutationAssessor | Pathogenic | 3.3 | M |
PhyloP100 | Benign | 0.83 | |
popEVE | Benign | -3.4 | |
PrimateAI | Uncertain | 0.74 | T |
PROVEAN | Pathogenic | -7.3 | D |
REVEL | Pathogenic | 0.75 | |
Sift | Pathogenic | 0.0 | D |
Sift4G | Pathogenic | 0.0 | D |
Varity_R | N/A | 0.80 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.050 | |
SpliceAI score (max) | Benign | 0.12 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.